References
- Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011;22:2675–86.
- Jamema SV, Kirisits C, Mahantshetty U, Trnkova P, Deshpande DD, Shrivastava SK, et al. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases. Radiother Oncol 2010; 97:501–6.
- Jamema SV, Sharma S, Mahantshetty U, Engineer R, Shrivastava SK, Deshpande DD. Comparison of IPSA with dose-point optimization and manual optimization for interstitial template brachytherapy for gynecologic cancers. Brachytherapy 2011;10:306–12.
- Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high- dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys 2003;57:1010–8.
- Haie-Meder C, Potter R, van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–45.
- Potter R, Haie-Meder C, van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.
- Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 2001;50:1123–35.
- Hall EJ, Giaccia A. Radiobiology for the radiologist, 6th ed. Lippincott Williams & Wilkins: Philadelphia; 2006.
- Chajon E, Dumas I, Touleimat M, Magne N, Coulot J, Verstraet R, et al. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer. Int J Radiat Oncol Biol Phys 2007;69:955–61.
- Baltas D, Kolotas C, Geramani K, Mould RF, Ioannidis G, Kekchidi M, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998;40:515–24.
- Lessard E, Hsu IC, Pouliot J. Inverse planning for interstitial gynecologic template brachytherapy: Truly anatomy-based planning. Int J Radiat Oncol Biol Phys 2002;54:1243–51.
- Dewitt KD, Hsu IC, Speight J, Weinberg VK, Lessard E, Pouliot J. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys 2005;63:1270–4.
- Al Booz H, Boiangiu I, Appleby H, French C, Coomber H, Humphery P, et al. Sigmoid colon is an unexpected organ at risk in brachytherapy for cervix cancer. J Egypt Natl Cancer Inst 2006;18:156–60.
- Vikram B, Deore S, Beitler JJ, Sood B, Mullokandov E, Kapulsky A, et al. The relationship between dose heterogeneity (“hot” spots) and complications following high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1999; 43:983–7.